Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 7.67 M7.83 M8.25 M8.3 M9 M 33.38 M Research & development ————— — Operating income 4.84 M4.04 M1.33 M-884 K1.26 M 5.75 M Non-Operating Income, Total 265 K168 K149 K1.14 M-212 K 1.25 M Interest expense, net of interest capitalized 15 K15 K15 K96 K189 K 315 K Non-Operating Income, excl. Interest Expenses 258 K148 K122 K972 K-190 K 1.05 M Unusual income/expense 7 00020 K27 K168 K-22 K 193 K Pretax income 5.1 M4.21 M1.48 M256 K1.05 M 7 M Equity in earnings -347 K-843 K-11 K877 K0 23 K Taxes 1.17 M1.06 M391 K363 K517 K 2.33 M Non-controlling/minority interest 1.46 M1.23 M471 K13 K296 K 2.01 M After tax other income/expense ————— — Net income before discontinued operations 2.47 M1.92 M618 K-120 K237 K 2.65 M Discontinued operations ————— — Net income 2.47 M1.92 M618 K-120 K237 K 2.65 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 2.47 M1.92 M618 K-120 K237 K 2.65 M Basic earnings per share (Basic EPS) 0.260.210.07-0.010.03 0.3 Diluted earnings per share (Diluted EPS) 0.260.210.07-0.010.03 0.3 Average basic shares outstanding 9.58 M9.1 M8.37 M8.02 M7.68 M — Diluted shares outstanding 9.62 M9.12 M8.39 M8.02 M7.73 M — EBITDA 5.88 M5.12 M2.39 M-1.64 M2.35 M 8.22 M EBIT 4.84 M4.04 M1.33 M-884 K1.26 M 5.75 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 1.04 M1.08 M1.06 M-755 K1.09 M 2.47 M